Focus

antiviral pill

LATEST

COVID-19
COVID-19

9 Things You Need to Know About Paxlovid

9 Things You Need to Know About Paxlovid
|
Businesses in COVID-19
Businesses in COVID-19

Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill

Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill
|
UK News
UK News

Pfizer’s Antiviral COVID-19 Pill Approved by Britain’s Health Regulators

Pfizer’s Antiviral COVID-19 Pill Approved by Britain’s Health Regulators
|
NTD Evening News
NTD Evening News

NTD Evening News Full Broadcast (Dec. 23)

NTD Evening News Full Broadcast (Dec. 23)
|
COVID-19
COVID-19

9 Things You Need to Know About Paxlovid

9 Things You Need to Know About Paxlovid
|
Businesses in COVID-19
Businesses in COVID-19

Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill

Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill
|
UK News
UK News

Pfizer’s Antiviral COVID-19 Pill Approved by Britain’s Health Regulators

Pfizer’s Antiviral COVID-19 Pill Approved by Britain’s Health Regulators
|
NTD Evening News
NTD Evening News

NTD Evening News Full Broadcast (Dec. 23)

NTD Evening News Full Broadcast (Dec. 23)
|